A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus (opens ClinicalTrials.gov)
- Sponsor
- Novo Nordisk A/S
- Enrolment
- 1,012
- Started
- 2016-01-31
- Last update
- 2019-11-27
Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: insulin degludec/liraglutide, insulin glargine